Doximity, which ranks fifth on the IBD 50, crushed December-quarter expectations late Thursday and raised its outlook for the ...
Construction materials supplier CRH cleared a buy point Thursday after announcing plans to unload its stake in SigmaRoc.
Investor's Business Daily on MSN14h
Kemper Stock Gets IBD Rating Upgrade
This unique rating measures technical performance by showing how a stock's price movement over the last 52 weeks compares to ...
Diet plays a pivotal role in influencing autoimmune diseases like multiple sclerosis (MS), inflammatory bowel disease, and ...
Mozart Therapeutics, the leading developer of CD8 Treg network modulators in autoimmune disease, announces the presentation ...